Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice

BACKGROUND: Microthrombi formation in the cerebral microvasculature has been demonstrated in animal models of subarachnoid hemorrhage (SAH) as well as autopsy studies of patients with aneurysmal SAH, and microthrombi are thought to contribute to delayed cerebral ischemia and poor neurological outcomes. Our hypothesis was that treatment with tirofiban, an antiplatelet drug that inhibits glycoprotein IIb/IIIa, would reduce microthrombi formation and the subsequent sequalae, delayed cerebral ischemia, in aged mice. METHODS: SAH was induced via endovascular perforation in male mice, and blood injection in female mice, followed by treatment with either tirofiban or saline. Mice underwent daily neurological assessment for 6 days and then were euthanized. Magnetic resonance imaging scans were obtained on days 2, 4, and 6 after SAH to identify infarcted tissue. Magnetic resonance imaging perfusion and laser speckle contrast imaging were performed to evaluate cerebral perfusion. Postmortem microthrombi formation in the cerebral microvascular was quantified. RESULTS: Tirofiban treatment in male mice, compared with saline, led to reduced microthrombi formation, and prevented delayed infarct growth and neurological decline. In female mice, significant neurobehavioral improvements were observed, which corresponded with fewer brain microthrombi. No female mice had infarction, nor was delayed cerebral ischemia detected in any female mouse. CONCLUSIONS: After SAH in mice, treatment with tirofiban reduces both cerebral microthrombi formation and delayed infarct growth leading to a subsequent improvement in neurological outcomes.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-11-12
DOI
https://doi.org/10.1161/jaha.126.049332
Primary Topic
Intracranial Aneurysms: Treatment and Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice

Devin William McBride, Peeyush Kumar Thankamani Pandit, William Walker Wroe, Kiara Torres et al.
Journal of the American Heart Association
Intracranial Aneurysms: Treatment and Complications
article

Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice

Devin William McBride, Peeyush Kumar Thankamani Pandit, William Walker Wroe, Kiara Torres, Spiros Blackburn, Ari Dienel, Richard Cook, Shuning Huang, Srilatha Potluri, Samitha Nemirajaiah, Harveen Kaur, Sanjana Kavula, Sung‐Ha Hong
article en

Abstract

BACKGROUND: Microthrombi formation in the cerebral microvasculature has been demonstrated in animal models of subarachnoid hemorrhage (SAH) as well as autopsy studies of patients with aneurysmal SAH, and microthrombi are thought to contribute to delayed cerebral ischemia and poor neurological outcomes. Our hypothesis was that treatment with tirofiban, an antiplatelet drug that inhibits glycoprotein IIb/IIIa, would reduce microthrombi formation and the subsequent sequalae, delayed cerebral ischemia, in aged mice. METHODS: SAH was induced via endovascular perforation in male mice, and blood injection in female mice, followed by treatment with either tirofiban or saline. Mice underwent daily neurological assessment for 6 days and then were euthanized. Magnetic resonance imaging scans were obtained on days 2, 4, and 6 after SAH to identify infarcted tissue. Magnetic resonance imaging perfusion and laser speckle contrast imaging were performed to evaluate cerebral perfusion. Postmortem microthrombi formation in the cerebral microvascular was quantified. RESULTS: Tirofiban treatment in male mice, compared with saline, led to reduced microthrombi formation, and prevented delayed infarct growth and neurological decline. In female mice, significant neurobehavioral improvements were observed, which corresponded with fewer brain microthrombi. No female mice had infarction, nor was delayed cerebral ischemia detected in any female mouse. CONCLUSIONS: After SAH in mice, treatment with tirofiban reduces both cerebral microthrombi formation and delayed infarct growth leading to a subsequent improvement in neurological outcomes.

Journal of the American Heart Association
Rice University (US), The University of Texas Health Science Center at Houston (US)
Good health and well-being
Intracranial Aneurysms: Treatment and Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon